GENEXPERT XVI
Device
Cepheid
Total Payments
$94,995
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $94,995 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $94,995 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Protocol 265B, Clinical Evaluation of Xpert Insight Breast Cancer Signature using Formalin Fixed Paraffin Embedded Specimens from Breast Cancer Patients | Cepheid | $94,995 | 0 |
Top Doctors Receiving Payments for GENEXPERT XVI
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Ann Arbor, MI | $94,995 | 1 |
About GENEXPERT XVI
GENEXPERT XVI is a device associated with $94,995 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is Cepheid.
Payment data is available from 2021 to 2021. In 2021, $94,995 was paid across 1 transactions to 0 doctors.
The most common payment nature for GENEXPERT XVI is "Unspecified" ($94,995, 100.0% of total).
GENEXPERT XVI is associated with 1 research study, including "Protocol 265B, Clinical Evaluation of Xpert Insight Breast Cancer Signature using Formalin Fixed Paraffin Embedded Specimens from Breast Cancer Patients" ($94,995).